Anupam Rasayan Reports Strong Q2 & H1 FY26 Results; Consolidated Revenue up 149% in Q2
Anupam Rasayan reported stellar Q2 and H1 FY26 results with consolidated revenue up 149% and 121% respectively. MD notes it as one of the best quarters, surpassing FY25 revenue in H1.
The announcement details strong financial results with substantial growth, provides a comprehensive business overview including new product additions, a robust order book of ₹14,646 crore, and strategic initiatives like backward integration through Tanfac acquisition and expansion into fluorination chemistry. These details suggest a significant positive impact on the company's valuation and future prospects.
The company reported significant year-on-year growth across all key financial metrics (revenue, EBITDA, PAT) for both Q2 and H1 FY26, on both consolidated and standalone bases. The Managing Director expressed strong satisfaction, calling Q2 one of the best quarters and highlighting that half-year revenue already surpassed the previous full fiscal year's revenue, indicating robust performance and positive outlook.
* Anupam Rasayan India Limited released its Investor Presentation for the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30, 2025. * Consolidated Financial Highlights for Q2 FY26: * Total Revenue: ₹7,392 Mn (₹739.2 crore), a Year-on-Year (Y-o-Y) growth of 149%. * EBITDA: ₹1,436 Mn (₹143.6 crore), a Y-o-Y growth of 74%. * PAT: ₹572 Mn (₹57.2 crore), a Y-o-Y growth of 87%. * Consolidated Financial Highlights for H1 FY26: * Total Revenue: ₹12,299 Mn (₹1,229.9 crore), a Y-o-Y growth of 121%. * EBITDA: ₹2,728 Mn (₹272.8 crore), a Y-o-Y growth of 93%. * PAT: ₹1,056 Mn (₹105.6 crore), a Y-o-Y growth of 147%. * Management Commentary: Mr. Anand S Desai, Managing Director, stated that Q2 FY26 was
What to do with a filing like this
Anupam Rasayan India Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Anupam Rasayan India Limited. Read the original for the full detail.